CN112370480A - Acupoint application for treating paroxysmal atrial fibrillation and using method thereof - Google Patents

Acupoint application for treating paroxysmal atrial fibrillation and using method thereof Download PDF

Info

Publication number
CN112370480A
CN112370480A CN202011387244.1A CN202011387244A CN112370480A CN 112370480 A CN112370480 A CN 112370480A CN 202011387244 A CN202011387244 A CN 202011387244A CN 112370480 A CN112370480 A CN 112370480A
Authority
CN
China
Prior art keywords
atrial fibrillation
frankincense
myrrh
rhizoma corydalis
asarum
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202011387244.1A
Other languages
Chinese (zh)
Inventor
王伟学
杨华
汪亚峰
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN202011387244.1A priority Critical patent/CN112370480A/en
Publication of CN112370480A publication Critical patent/CN112370480A/en
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/31—Brassicaceae or Cruciferae (Mustard family), e.g. broccoli, cabbage or kohlrabi
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/26—Aristolochiaceae (Birthwort family), e.g. heartleaf
    • A61K36/268—Asarum (wild ginger)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/32—Burseraceae (Frankincense family)
    • A61K36/324—Boswellia, e.g. frankincense
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/32—Burseraceae (Frankincense family)
    • A61K36/328—Commiphora, e.g. mecca myrrh or balm of Gilead
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/47—Euphorbiaceae (Spurge family), e.g. Ricinus (castorbean)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/54—Lauraceae (Laurel family), e.g. cinnamon or sassafras
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/66—Papaveraceae (Poppy family), e.g. bloodroot
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Mycology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

The invention discloses an acupoint application for treating paroxysmal atrial fibrillation and a using method thereof, wherein the acupoint application is prepared from the following raw materials: 19-23 g of white mustard seed, 18-24 g of euphorbia kansui, 10-14 g of rhizoma corydalis, 9-15 g of asarum, 8-12 g of frankincense, 9-11 g of myrrh, 4-8 g of cinnamon and 1-3 g of borneol, wherein the best embodiment mode is 21g of white mustard seed, 21g of euphorbia kansui, 12g of rhizoma corydalis, 12g of asarum, 10g of frankincense, 10g of myrrh, 6g of cinnamon and 1g of borneol. According to the scheme of the invention, the frankincense, myrrh and rhizoma corydalis which are blood-activating and stasis-removing medicines are added, so that the effects of activating blood and removing stasis are achieved; the acupoint application scheme takes care of the requirement of the cardio-pulmonary-splenic co-treatment of the traditional Chinese medicine, and is more suitable for the traditional Chinese medicine pathogenesis of atrial fibrillation patients with the same heart, lung and spleen diseases compared with the traditional Chinese medicine application, the recurrence rate of paroxysmal atrial fibrillation can be expected to be reduced, and the recurrence rate of the atrial fibrillation patients after radio frequency ablation is reduced.

Description

Acupoint application for treating paroxysmal atrial fibrillation and using method thereof
Technical Field
The invention relates to the technical field of acupoint application, in particular to an acupoint application for treating paroxysmal atrial fibrillation and a using method thereof.
Background
Paroxysmal atrial fibrillation is an intermittent rapid and irregular atrial rhythm due to multiple reentry wavelets, and is ectopic tachycardia with a pacing point in the atrium. Irregular impulses occur to the atria at the time of attack for 350-600 times/min, and uncoordinated atrial fibrillation is caused. The atrioventricular conduction system can only receive some of the conduction of atrial excitation. The ventricular beats fast and irregularly during paroxysmal atrial fibrillation, and the beating time is 120-180 times/min. Paroxysmal atrial fibrillation is one of the most common arrhythmia of adults, and is far more common than atrial flutter, and the incidence rate ratio of the two is 10-20: 1. Paroxysmal episodes may be converted to persistent by repeated attacks.
The traditional Chinese medicine application medicine in the prior art mainly adopts a warm-dispersing medicine, is more suitable for treating chronic cough and asthma, can remove long-term phlegm and deficiency of lung and spleen, and cannot meet the treatment requirement of patients with chronic heart disease and atrial fibrillation with heart, lung, spleen and multiple viscera.
Disclosure of Invention
The present invention is directed to solving the above problems and providing an acupoint application for treating paroxysmal atrial fibrillation and a method of using the same.
The invention realizes the purpose through the following technical scheme:
an acupoint application for treating paroxysmal atrial fibrillation is prepared from the following raw materials: 19-23 g of white mustard seed, 18-24 g of euphorbia kansui, 10-14 g of rhizoma corydalis, 9-15 g of asarum, 8-12 g of frankincense, 9-11 g of myrrh, 4-8 g of cinnamon and 1-3 g of borneol.
As the best mode among them: the preparation method is characterized by comprising the following raw materials: 21g of white mustard seed, 21g of euphorbia kansui, 12g of rhizoma corydalis, 12g of asarum, 10g of frankincense, 10g of myrrh, 6g of cinnamon and 1g of borneol.
As one of the embodiments: the preparation method is characterized by comprising the following raw materials: 19g of white mustard seed, 18g of euphorbia kansui, 10g of rhizoma corydalis, 9g of asarum, 8g of frankincense, 9g of myrrh, 4g of cinnamon and 1g of borneol.
As one of the embodiments: the preparation method is characterized by comprising the following raw materials: 23g of white mustard seed, 24g of euphorbia kansui, 14g of rhizoma corydalis, 15g of asarum, 12g of frankincense, 11g of myrrh, 8g of cinnamon and 3g of borneol.
As one of the embodiments: the preparation method is characterized by comprising the following raw materials: 19g of white mustard seed, 24g of euphorbia kansui, 10g of rhizoma corydalis, 15g of asarum, 8g of frankincense, 11g of myrrh, 4g of cinnamon and 3g of borneol.
As one of the embodiments: the preparation method is characterized by comprising the following raw materials: 23g of white mustard seed, 18g of euphorbia kansui, 14g of rhizoma corydalis, 9g of asarum, 12g of frankincense, 9g of myrrh, 8g of cinnamon and 1g of borneol.
The invention also provides a use method of the acupoint application for treating paroxysmal atrial fibrillation, white mustard seed, euphorbia kansui, rhizoma corydalis, asarum, frankincense, myrrh and cinnamon are ground into powder, rice vinegar is adopted to blend the powder into paste, each medicine cake is added with borneol to be applied to the acupoints, and the acupoint selection is as follows: neiguan, Xinshu, Pishu, Guanyuan or Jueyinshu, Geshu, Juque and Zusanli, which are used alternately, 2-4 h each time, and applied once every 4 days.
The raw material effects are as follows:
white mustard seed: warming lung, eliminating phlegm and promoting qi circulation; can be used for treating cough and asthma due to cold phlegm, distending pain in chest and hypochondrium, phlegm stagnation in channels and collaterals, numbness and pain of joints, phlegm dampness and fluid injection, and carbuncle of yin and swelling.
Euphorbia kansui: purging water, dispelling swelling, relieving swelling, and resolving hard mass; mainly treats edema; ascites fluid; retained fluid and accumulated in chest; epilepsy; cough and asthma; defecate and stool.
Rhizoma corydalis: rhizoma corydalis is pungent and bitter in flavor and warm in nature; has effects in promoting blood circulation, dispelling blood stasis, regulating qi, and relieving pain.
Asarum: relieving exterior syndrome, dispelling cold, dispelling pathogenic wind, relieving pain, dredging orifice, warming lung, and eliminating phlegm; can be used for treating common cold due to wind-cold, headache, toothache, nasal obstruction, nasal discharge, allergic rhinitis, nasosinusitis, rheumatic arthralgia, phlegm and fluid retention, and cough and asthma.
Frankincense: promoting blood circulation, activating qi-flowing, relieving pain, relieving swelling, and promoting granulation; can be used for treating thoracic obstruction, cardialgia, epigastralgia, dysmenorrhea, amenorrhea, puerperal blood stasis, abdominal pain, rheumatic arthralgia, spasm of muscles and tendons, traumatic injury, carbuncle, swelling, and pyocutaneous disease.
Myrrh: removing blood stasis, relieving pain, eliminating swelling, and promoting granulation; can be used for treating thoracic obstruction, cardialgia, gastralgia, dysmenorrhea, amenorrhea, puerperal blood stasis, abdominal mass, rheumatic arthralgia, traumatic injury, carbuncle, swelling, and pyocutaneous disease.
Cinnamon: has the effects of tonifying fire, supporting yang, guiding fire to the origin, dispelling cold, relieving pain, and warming and dredging channels and collaterals; can be used for treating sexual impotence, cold womb, cold pain of waist and knee, asthma due to kidney deficiency, floating of deficient yang, giddiness, conjunctival congestion, cold pain of heart and abdomen, vomiting and diarrhea due to deficiency cold, cold hernia, abdominal pain, dysmenorrhea, and amenorrhea.
Borneol: has effects of inducing resuscitation, refreshing mind, clearing away heat, removing toxic substances, improving eyesight, and eliminating nebula; can be used for treating fever, hyperpyrexia, coma, apoplexy, phlegm syncope, convulsion, summer-heat, dampness, obstruction of the channels, laryngopharyngitis, deafness, aphtha, dental swelling, skin ulcer, carbuncle, hemorrhoid, conjunctival congestion, swelling and pain, nebula, and ophthalmopathy.
The invention has the following advantages:
1. the medicine with the effects of promoting blood circulation and removing blood stasis, such as frankincense, myrrh and rhizoma corydalis, is added into the scheme, so that the effect of promoting blood circulation and removing blood stasis is achieved;
2. the acupoint application scheme takes care of the requirement of the cardio-pulmonary-splenic co-treatment of the traditional Chinese medicine, and is more suitable for the traditional Chinese medicine pathogenesis of atrial fibrillation patients with the same heart, lung and spleen diseases compared with the traditional Chinese medicine application, the recurrence rate of paroxysmal atrial fibrillation can be expected to be reduced, and the recurrence rate of the atrial fibrillation patients after radio frequency ablation is reduced.
Detailed Description
The present invention will be further described with reference to specific examples, but the present invention is not limited to these examples.
Example 1
An acupoint application for treating paroxysmal atrial fibrillation is prepared from the following raw materials: 21g of white mustard seed, 21g of euphorbia kansui, 12g of rhizoma corydalis, 12g of asarum, 10g of frankincense, 10g of myrrh, 6g of cinnamon and 1g of borneol.
Example 2
An acupoint application for treating paroxysmal atrial fibrillation is prepared from the following raw materials: 19g of white mustard seed, 18g of euphorbia kansui, 10g of rhizoma corydalis, 9g of asarum, 8g of frankincense, 9g of myrrh, 4g of cinnamon and 1g of borneol.
Example 3
An acupoint application for treating paroxysmal atrial fibrillation is prepared from the following raw materials: 23g of white mustard seed, 24g of euphorbia kansui, 14g of rhizoma corydalis, 15g of asarum, 12g of frankincense, 11g of myrrh, 8g of cinnamon and 3g of borneol.
Example 4
An acupoint application for treating paroxysmal atrial fibrillation is prepared from the following raw materials: 19g of white mustard seed, 24g of euphorbia kansui, 10g of rhizoma corydalis, 15g of asarum, 8g of frankincense, 11g of myrrh, 4g of cinnamon and 3g of borneol.
Example 5
An acupoint application for treating paroxysmal atrial fibrillation is prepared from the following raw materials: 23g of white mustard seed, 18g of euphorbia kansui, 14g of rhizoma corydalis, 9g of asarum, 12g of frankincense, 9g of myrrh, 8g of cinnamon and 1g of borneol.
The invention also provides a use method of the acupoint application for treating paroxysmal atrial fibrillation, white mustard seed, euphorbia kansui, rhizoma corydalis, asarum, frankincense, myrrh and cinnamon are ground into powder, rice vinegar is adopted to blend the powder into paste, each medicine cake is added with borneol to be applied to the acupoints, and the acupoint selection is as follows: neiguan, Xinshu, Pishu, Guanyuan or Jueyinshu, Geshu, Juque and Zusanli, which are used alternately, 2-4 h each time, and applied once every 4 days.
The method can obtain the following components in practice: the best mode is 21g of white mustard seed, 21g of euphorbia kansui, 12g of rhizoma corydalis, 12g of asarum, 10g of frankincense, 10g of myrrh, 6g of cinnamon and 1g of borneol.
The above-mentioned embodiments only express the embodiments of the present invention, and the description thereof is more specific and detailed, but not construed as limiting the scope of the present invention. It should be noted that, for a person skilled in the art, several variations and modifications can be made without departing from the inventive concept, which falls within the scope of the present invention.

Claims (7)

1. An acupuncture point application for treating paroxysmal atrial fibrillation, which is characterized in that: the preparation method is characterized by comprising the following raw materials: 19-23 g of white mustard seed, 18-24 g of euphorbia kansui, 10-14 g of rhizoma corydalis, 9-15 g of asarum, 8-12 g of frankincense, 9-11 g of myrrh, 4-8 g of cinnamon and 1-3 g of borneol.
2. The patch for the treatment of paroxysmal atrial fibrillation according to claim 1, wherein: the preparation method is characterized by comprising the following raw materials: 21g of white mustard seed, 21g of euphorbia kansui, 12g of rhizoma corydalis, 12g of asarum, 10g of frankincense, 10g of myrrh, 6g of cinnamon and 1g of borneol.
3. The patch for the treatment of paroxysmal atrial fibrillation according to claim 1, wherein: the preparation method is characterized by comprising the following raw materials: 19g of white mustard seed, 18g of euphorbia kansui, 10g of rhizoma corydalis, 9g of asarum, 8g of frankincense, 9g of myrrh, 4g of cinnamon and 1g of borneol.
4. The patch for the treatment of paroxysmal atrial fibrillation according to claim 1, wherein: the preparation method is characterized by comprising the following raw materials: 23g of white mustard seed, 24g of euphorbia kansui, 14g of rhizoma corydalis, 15g of asarum, 12g of frankincense, 11g of myrrh, 8g of cinnamon and 3g of borneol.
5. The patch for the treatment of paroxysmal atrial fibrillation according to claim 1, wherein: the preparation method is characterized by comprising the following raw materials: 19g of white mustard seed, 24g of euphorbia kansui, 10g of rhizoma corydalis, 15g of asarum, 8g of frankincense, 11g of myrrh, 4g of cinnamon and 3g of borneol.
6. The patch for the treatment of paroxysmal atrial fibrillation according to claim 1, wherein: the preparation method is characterized by comprising the following raw materials: 23g of white mustard seed, 18g of euphorbia kansui, 14g of rhizoma corydalis, 9g of asarum, 12g of frankincense, 9g of myrrh, 8g of cinnamon and 1g of borneol.
7. The method of using the acupoint application for the treatment of paroxysmal atrial fibrillation according to claim 1, wherein the acupoint application comprises: grinding semen Sinapis Albae, radix kansui, rhizoma corydalis, herba asari, Olibanum, Myrrha, and cortex Cinnamomi into powder, concocting with rice vinegar into paste, adding Borneolum Syntheticum into each medicinal cake, and applying to acupuncture points: neiguan, Xinshu, Pishu, Guanyuan or Jueyinshu, Geshu, Juque and Zusanli, which are used alternately, 2-4 h each time, and applied once every 4 days.
CN202011387244.1A 2020-12-02 2020-12-02 Acupoint application for treating paroxysmal atrial fibrillation and using method thereof Pending CN112370480A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202011387244.1A CN112370480A (en) 2020-12-02 2020-12-02 Acupoint application for treating paroxysmal atrial fibrillation and using method thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202011387244.1A CN112370480A (en) 2020-12-02 2020-12-02 Acupoint application for treating paroxysmal atrial fibrillation and using method thereof

Publications (1)

Publication Number Publication Date
CN112370480A true CN112370480A (en) 2021-02-19

Family

ID=74589533

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202011387244.1A Pending CN112370480A (en) 2020-12-02 2020-12-02 Acupoint application for treating paroxysmal atrial fibrillation and using method thereof

Country Status (1)

Country Link
CN (1) CN112370480A (en)

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109481554A (en) * 2017-09-11 2019-03-19 谭午兴 A kind of dog days' Chinese medicinal plaster and preparation method thereof

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109481554A (en) * 2017-09-11 2019-03-19 谭午兴 A kind of dog days' Chinese medicinal plaster and preparation method thereof

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
李可法等: "中西医综合疗法治疗类风湿性关节炎93例", 《国医论坛》 *

Similar Documents

Publication Publication Date Title
CN106822272B (en) Plaster
CN1294957C (en) Ointment for treating spur
CN112370480A (en) Acupoint application for treating paroxysmal atrial fibrillation and using method thereof
CN110755517A (en) Pain-relieving liquid
CN111297998A (en) Pain-relieving liquid
CN104825578A (en) Drug for promoting recovery after facial nerve injury surgery anastomosis
CN104435783A (en) Energy health-preserving moxibustion compound and using method thereof
CN1628802A (en) Healthy Chinese medicinal liquor for fire therapy
CN107115505A (en) A kind of promoting blood circulation analgesic plaster and preparation method thereof
CN112168905A (en) Traditional Chinese medicine joint pain relieving plaster and preparation method thereof
CN103961618A (en) Plaster for treating pains caused by wind-cold damp pathogens
CN104367679A (en) Traditional Chinese medicine composition ointment for treating rheumatism and bone diseases
CN109172786A (en) A kind of draft energy mud formula of clearing damp dispelling cold and preparation method thereof
CN108434282A (en) A kind of Chinese medicine composition for treating osteoproliferation
CN104740352A (en) External traditional Chinese medicine ointment for treating facial paralysis
CN106692607A (en) Anticancer Chinese patent medicine for multiple cancers
CN105233158A (en) Traditional Chinese medicinal composition for treating cervical spondylosis and preparation method of traditional Chinese medicinal composition
CN105012600A (en) External medicine for treating hyperostosis and herniated disk
CN105288164A (en) Traditional Chinese medicine composition for curing chronic eczema and preparation method of traditional Chinese medicine composition
CN114042033A (en) Plaster for cervical vertebra and lumbar vertebra and preparation method thereof
CN113230378A (en) Traditional Chinese medicine moxibustion product for rheumatism as well as preparation method and use method thereof
CN115227758A (en) Traditional Chinese medicine composition for treating scapulohumeral periarthritis
CN105497693A (en) Traditional Chinese medicine for treating nodular fasciitis
CN117797207A (en) Externally applied plaster for treating wind-damp-cold arthralgia and preparation method thereof
CN102872436A (en) Chinese medicinal composition for treating gall stones

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication

Application publication date: 20210219

RJ01 Rejection of invention patent application after publication